Search research articles
Contact Us
Filters
Showing results (81-90 of 197) with videos related to
Page
of 20
Sort By:
Pharmacology & Toxicology
|
April 1, 1987
Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment
K Brøsen, L F Gram, T Haghfelt, et al.
European Journal of Clinical Pharmacology
|
January 1, 1988
Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department
F Davidsen, T Haghfelt, L F Gram, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1991
The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine
E Skjelbo, K Brøsen, J Hallas, et al.
The Clinical Journal of Pain
|
June 1, 1992
Plasma beta-endorphin is not affected by treatment with imipramine or paroxetine in patients with diabetic neuropathy symptoms
S H Sindrup, F W Bach, L F Gram
Lancet (London, England)
|
October 15, 1994
Misuse of sumatriptan
D Gaist, S Sindrup, J Hallas, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics
K Brøsen, L F Gram, R Klysner, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1971
Imipramine metabolism: pH-dependent distribution and urinary excretion
L F Gram, B Kofod, J Christiansen, et al.
Clinical Pharmacokinetics
|
July 1, 1980
Plasma concentration and clinical effect in imipramine treatment of childhood enuresis
O S Jorgensen, M Lober, J Christiansen, et al.
British Journal of Clinical Pharmacology
|
April 1, 1996
Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994
D Gaist, J Hallas, N C Hansen, et al.
Scandinavian Journal of Primary Health Care
|
December 1, 1995
Antidepressant treatment in general practice--an interview study
J U Rosholm, L F Gram, N Damsbo, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 197) with videos related to
Sort By:
Page
of 20
Pharmacology & Toxicology
|
April 1, 1987
Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment
K Brøsen, L F Gram, T Haghfelt, et al.
European Journal of Clinical Pharmacology
|
January 1, 1988
Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department
F Davidsen, T Haghfelt, L F Gram, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1991
The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine
E Skjelbo, K Brøsen, J Hallas, et al.
The Clinical Journal of Pain
|
June 1, 1992
Plasma beta-endorphin is not affected by treatment with imipramine or paroxetine in patients with diabetic neuropathy symptoms
S H Sindrup, F W Bach, L F Gram
Lancet (London, England)
|
October 15, 1994
Misuse of sumatriptan
D Gaist, S Sindrup, J Hallas, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics
K Brøsen, L F Gram, R Klysner, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1971
Imipramine metabolism: pH-dependent distribution and urinary excretion
L F Gram, B Kofod, J Christiansen, et al.
Clinical Pharmacokinetics
|
July 1, 1980
Plasma concentration and clinical effect in imipramine treatment of childhood enuresis
O S Jorgensen, M Lober, J Christiansen, et al.
British Journal of Clinical Pharmacology
|
April 1, 1996
Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994
D Gaist, J Hallas, N C Hansen, et al.
Scandinavian Journal of Primary Health Care
|
December 1, 1995
Antidepressant treatment in general practice--an interview study
J U Rosholm, L F Gram, N Damsbo, et al.
Page
of 20